Search

Author/Creator Socinski, Mark A.

2. A Randomized Phase II Study of Carboplatin With Weekly or Every-3-Week Nanoparticle Albumin-Bound Paclitaxel (Abraxane) in Patients With Extensive-Stage Small Cell Lung Cancer. (23rd January 2015)

Authors:
Grilley-Olson, Juneko E.; Keedy, Vicki L.; Sandler, Alan; Moore, Dominic T.; Socinski, Mark A.; Stinchcombe, Thomas E.
Journal:
Oncologist
Issue:
Volume 20:Number 2(2015)
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Randomized Phase II Study of Carboplatin With Weekly or Every‐3‐Week Nanoparticle Albumin‐Bound Paclitaxel (Abraxane) in Patients With Extensive‐Stage Small Cell Lung Cancer. (23rd January 2015)

Authors:
Grilley‐Olson, Juneko E.; Keedy, Vicki L.; Sandler, Alan; Moore, Dominic T.; Socinski, Mark A.; Stinchcombe, Thomas E.
Journal:
Oncologist
Issue:
Volume 20:Number 2(2015)
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors. Issue 9 (5th November 2022)

Authors:
Guo, Mengni; Liu, Jieying; Miao, Ruoyu; Ahmed, Zohaib; Yu, James; Guan, Jian; Ahmad, Sarfraz; Zhou, Shuntai; Grove, Angela; Manoucheri, Manoucher; Socinski, Mark A.; Mekhail, Tarek
Journal:
Journal of immunotherapy
Issue:
Volume 45:Issue 9(2022)
Page Start:
389
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC). (February 2017)

Authors:
Awad, Mark M.; Chu, Quincy S-C; Gandhi, Leena; Stephenson, Joe J.; Govindan, Ramaswamy; Bradford, Daniel S.; Bonomi, Philip D.; Ellison, David M.; Eaton, Keith D.; Fritsch, Holger; Munzert, Gerd; Johnson, Bruce E.; Socinski, Mark A.
Journal:
Lung cancer
Issue:
Volume 104(2017)
Page Start:
126
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Association between depth of response and survival in patients with advanced‐stage non–small cell lung cancer treated with first‐line chemotherapy. Issue 14 (1st April 2019)

Authors:
Morgensztern, Daniel; Ko, Amy; O'Brien, Mary; Ong, Teng Jin; Waqar, Saiama N.; Socinski, Mark A.; Postmus, Pieter E.; Bhore, Rafia
Journal:
Cancer
Issue:
Volume 125:Issue 14(2019)
Page Start:
2394
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Issue 3 (1st October 2014)

Authors:
Villaruz, Liza C.; Socinski, Mark A.; Abberbock, Shira; Berry, Lynne D.; Johnson, Bruce E.; Kwiatkowski, David J.; Iafrate, A. John; Varella‐Garcia, Marileila; Franklin, Wilbur A.; Camidge, D. Ross; Sequist, Lecia V.; Haura, Eric B.; Ladanyi, Mark; Kurland, Brenda F.; Kugler, Kelly; Minna, John D...
Journal:
Cancer
Issue:
Volume 121:Issue 3(2015)
Page Start:
448
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Issue 3 (1st October 2014)

Authors:
Villaruz, Liza C.; Socinski, Mark A.; Abberbock, Shira; Berry, Lynne D.; Johnson, Bruce E.; Kwiatkowski, David J.; Iafrate, A. John; Varella‐Garcia, Marileila; Franklin, Wilbur A.; Camidge, D. Ross; Sequist, Lecia V.; Haura, Eric B.; Ladanyi, Mark; Kurland, Brenda F.; Kugler, Kelly; Minna, John D...
Journal:
Cancer
Issue:
Volume 121:Issue 3(2015)
Page Start:
448
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinicopathologic Features of Advanced Squamous NSCLC. Issue 9 (September 2016)

Authors:
Socinski, Mark A.; Obasaju, Coleman; Gandara, David; Hirsch, Fred R.; Bonomi, Philip; Bunn, Paul; Kim, Edward S.; Langer, Corey J.; Natale, Ronald B.; Novello, Silvia; Paz‐Ares, Luis; Pérol, Maurice; Reck, Martin; Ramalingam, Suresh S.; Reynolds, Craig H.; Spigel, David R.; Stinchcombe, Thomas E....
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 9(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer. Issue 2 (November 2017)

Authors:
Wang, Kyle; Pearlstein, Kevin A.; Patchett, Nicholas D.; Deal, Allison M.; Mavroidis, Panayiotis; Jensen, Brian C.; Lipner, Matthew B.; Zagar, Timothy M.; Wang, Yue; Lee, Carrie B.; Eblan, Michael J.; Rosenman, Julian G.; Socinski, Mark A.; Stinchcombe, Thomas E.; Marks, Lawrence B.
Journal:
Radiotherapy and oncology
Issue:
Volume 125:Issue 2(2017:Nov.)
Page Start:
293
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗